glucagon like peptide 1 glp 1 agonists glp-1_analogs [TUSOM Glucagon-like peptide-1 receptor: mechanisms and
Description
Follow Reza Hosseini Ghomi, MD, MSE for brain health that cuts through the hype Repost if you think more people should know about this Are you on a GLP-1

and in July 2024, the FDA approved Kisunla (donanemab) for early symptomatic Alzheimers, based on evidence of reduced clinical decline and a limitedduration regimen tied to amyloid plaque removal

GLP-1= glucagon-like peptide-1

This study demonstrated that the long-acting GLP-1R agonist, NLY01, has different health benefits in two different mouse models of MS

30 Berberine Patches Minimal-effort patches to complement your weight loss journey
The key takeaway
